diabetes-care
Diabetes Care (diabetes-care)
Journal positioning
Diabetes Care is the clinical flagship of the American Diabetes Association and the highest-impact clinical diabetes journal worldwide. Its editorial identity is firmly clinical and translational — randomized trials, epidemiology, clinical care delivery, and applied translational research in type 1 and type 2 diabetes, obesity, and related metabolic conditions — with an explicit emphasis on evidence that can change diabetes clinical practice or ADA Standards of Care. Unlike broader endocrinology journals, Diabetes Care does not publish basic molecular-biology studies without direct clinical application, and unlike general medical journals, it does not demand the single global significance of NEJM or JAMA. The readership is the ADA membership: diabetologists, endocrinologists, diabetes educators, and clinical researchers in cardiometabolic disease.
This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the ADA / Diabetes Care platform.
When to trigger
- The author names Diabetes Care or the ADA as the target venue for a diabetes or metabolic disease manuscript.
- A diabetes RCT, observational cohort, or technology study needs venue selection between Diabetes Care, Diabetologia, and broader medical journals.
- A paper directly relevant to ADA Standards of Care or clinical diabetes management guidelines needs framing guidance.
- The author needs Diabetes Care's desk-reject risks and alternative venues before submitting.